PROMIDISα: A T-cell receptor α signature associated with immunodeficiencies caused by V(D)J recombination defects.


Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
01 2019
Historique:
received: 20 11 2017
revised: 17 04 2018
accepted: 25 05 2018
pubmed: 16 6 2018
medline: 13 11 2019
entrez: 16 6 2018
Statut: ppublish

Résumé

V(D)J recombination ensures the diversity of the adaptive immune system. Although its complete defect causes severe combined immunodeficiency (ie, T We aimed at developing biomarkers based on analysis of the T-cell receptor (TCR) α repertoire to assist in the diagnosis of patients with primary immunodeficiencies with V(D)J recombination and DNA repair deficiencies. We used flow cytometric (fluorescence-activated cell sorting) analysis to quantify TCR-Vα7.2-expressing T lymphocytes in peripheral blood and developed PROMIDISα, a multiplex RT-PCR/next-generation sequencing assay, to evaluate a subset of the TCRα repertoire in T lymphocytes. The combined fluorescence-activated cell sorting and PROMIDISα analyses revealed specific signatures in patients with V(D)J recombination-defective primary immunodeficiencies or ataxia telangiectasia/Nijmegen breakage syndromes. Analysis of the TCRα repertoire is particularly appropriate in a prospective way to identify patients with partial immune defects caused by suboptimal V(D)J recombination activity, a DNA repair defect, or both. It also constitutes a valuable tool for the retrospective in vivo functional validation of variants identified through exome or panel sequencing. Its broader implementation might be of interest to assist early diagnosis of patients presenting with hypomorphic DNA repair defects inclined to experience acute toxicity during prehematopoietic stem cell transplantation conditioning.

Sections du résumé

BACKGROUND
V(D)J recombination ensures the diversity of the adaptive immune system. Although its complete defect causes severe combined immunodeficiency (ie, T
OBJECTIVE
We aimed at developing biomarkers based on analysis of the T-cell receptor (TCR) α repertoire to assist in the diagnosis of patients with primary immunodeficiencies with V(D)J recombination and DNA repair deficiencies.
METHODS
We used flow cytometric (fluorescence-activated cell sorting) analysis to quantify TCR-Vα7.2-expressing T lymphocytes in peripheral blood and developed PROMIDISα, a multiplex RT-PCR/next-generation sequencing assay, to evaluate a subset of the TCRα repertoire in T lymphocytes.
RESULTS
The combined fluorescence-activated cell sorting and PROMIDISα analyses revealed specific signatures in patients with V(D)J recombination-defective primary immunodeficiencies or ataxia telangiectasia/Nijmegen breakage syndromes.
CONCLUSION
Analysis of the TCRα repertoire is particularly appropriate in a prospective way to identify patients with partial immune defects caused by suboptimal V(D)J recombination activity, a DNA repair defect, or both. It also constitutes a valuable tool for the retrospective in vivo functional validation of variants identified through exome or panel sequencing. Its broader implementation might be of interest to assist early diagnosis of patients presenting with hypomorphic DNA repair defects inclined to experience acute toxicity during prehematopoietic stem cell transplantation conditioning.

Identifiants

pubmed: 29906526
pii: S0091-6749(18)30849-2
doi: 10.1016/j.jaci.2018.05.028
pii:
doi:

Substances chimiques

Receptors, Antigen, T-Cell, alpha-beta 0

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-334.e2

Informations de copyright

Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Aurélie Berland (A)

Laboratory "Genome Dynamics in the Immune System", INSERM UMR1163, Paris, France; Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France.

Jérémie Rosain (J)

Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France; Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (APHP), Necker Medical School, Paris, France.

Sophie Kaltenbach (S)

Laboratory "Genome Dynamics in the Immune System", INSERM UMR1163, Paris, France; Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France.

Vincent Allain (V)

Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (APHP), Necker Medical School, Paris, France.

Nizar Mahlaoui (N)

Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France; Pediatric Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Isabelle Melki (I)

Pediatric Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; General Pediatrics, Infectious Disease and Internal Medicine Department, Hôpital Robert Debré, (APHP), Paris, France.

Alice Fievet (A)

INSERM U830, Institut Curie, Paris, France; Service de Génétique, Institut Curie, Paris, France.

Catherine Dubois d'Enghien (C)

Service de Génétique, Institut Curie, Paris, France.

Marie Ouachée-Chardin (M)

Department of Pediatric Hematology, Robert-Debré (APHP), Paris, France.

Laurence Perrin (L)

Department of Genetics, Robert Debré Hospital, (APHP), Paris, France.

Nathalie Auger (N)

Department of Biopathology, Institut Gustave Roussy, Villejuif, France.

Funda Erol Cipe (FE)

Department of Pediatric Allergy-Immunology, Kanuni Sultan Suleyman Research and Training Hospital, Istanbul, Turkey.

Andrea Finocchi (A)

DPUO, University Department of Pediatrics, Bambino Gesù Children's Hospital and University of Tor Vergata School of Medicine, Rome, Italy.

Figen Dogu (F)

Department of Pediatric Immunology and Allergy, Ankara University School of Medicine, Ankara, Turkey.

Felipe Suarez (F)

Department of Haematology, Necker-Enfants Malades University Hospital, (APHP), Paris, France.

Despina Moshous (D)

Laboratory "Genome Dynamics in the Immune System", INSERM UMR1163, Paris, France; Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France; Pediatric Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Thierry Leblanc (T)

Department of Pediatric Hematology, Robert-Debré (APHP), Paris, France.

Alexandre Belot (A)

Pediatric Rheumatology, Nephrology and Dermatology Department, Hôpital Femme-Mère-Enfant, Hospices civils de Lyon, Lyon, France.

Claire Fieschi (C)

Department of Clinical Immunology, Hôpital Saint-Louis, (APHP), Paris, France.

David Boutboul (D)

Department of Clinical Immunology, Hôpital Saint-Louis, (APHP), Paris, France.

Marion Malphettes (M)

Department of Clinical Immunology, Hôpital Saint-Louis, (APHP), Paris, France.

Lionel Galicier (L)

Department of Clinical Immunology, Hôpital Saint-Louis, (APHP), Paris, France.

Eric Oksenhendler (E)

Department of Clinical Immunology, Hôpital Saint-Louis, (APHP), Paris, France.

Stéphane Blanche (S)

Pediatric Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Alain Fischer (A)

Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France; Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (APHP), Necker Medical School, Paris, France; INSERM UMR1163, Paris, France; Collège de France, Paris, France.

Patrick Revy (P)

Laboratory "Genome Dynamics in the Immune System", INSERM UMR1163, Paris, France; Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France.

Dominique Stoppa-Lyonnet (D)

INSERM U830, Institut Curie, Paris, France; Service de Génétique, Institut Curie, Paris, France; Université Paris Descartes Sorbonne Paris Cité, Paris, France.

Capucine Picard (C)

Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France; Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (APHP), Necker Medical School, Paris, France.

Jean-Pierre de Villartay (JP)

Laboratory "Genome Dynamics in the Immune System", INSERM UMR1163, Paris, France; Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France. Electronic address: devillartay@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH